Cannabis-focused SPAC, Pharma C Investments PLC,, applies for London listing

The company is a SPAC looking to invest in companies operating in the field of legalised medicinal cannabis

A special-purpose acquisition company (SPAC) looking for cannabis acquisitions has applied for admission to trade its shares on the Aquis Stock Exchange.

Pharma C Investments PLC, incorporated on 28 August 2018 as an investment vehicle and is designated as a SPAC under the AQSE Growth Market Access Rulebook, says its purpose is to identify investment opportunities and make acquisitions in companies operating in the field of legal medicinal cannabis.

The company said it will focus on identifying investment opportunities in companies that provide ancillary products and services that serve the medicinal cannabis sector.

The company mainly expects to be looking for companies operating in the United Kingdom, mainland Europe and Israel, all of which are internationally recognised as having well-developed and reputable laws and regulations for the research and production of medicinal cannabis and comply with the United Nations’ Convention on Narcotic Drugs.

The company said it expects to provide strategic insights and operational support to the companies in which it invests, helping them realise their growth strategy.

Primary Sponsor

Top Marijuana Blog